If you're working on a cancer-related project and want to speed up your research with our expert help contact our EU-OPENSCREEN helpdesk for possible collaboration options within the new canSERV transnational access call. 

As part of the canSERV consortium, EU-OPENSCREEN offers specialised services in drug discovery and chemical biology to help identify new, personalised cancer treatments. Our partner sites support your research with:

• High-throughput screening (HTS) using both target-based and phenotypic assays, including innovative 3D spheroid models

• Medicinal chemistry support to move promising compounds toward hit and lead validation

• Development of disease-relevant assays (2D/3D) for compound testing

• High-content imaging and profiling, even using patient-derived cells

• Biophysical methods to study drug-target interactions

• ADME-Tox studies for preclinical evaluation

• Support in biomarker discovery and metabolomic profiling of cancer stem cell-derived exosomes

Whether you're looking to screen new compounds, validate drug targets, or refine your personalised therapy strategies, EU-OPENSCREEN is your partner for turning innovative ideas into impactful cancer research.

Overall budget: 1.500.0000 EUR

Submission deadline: 15 July 2025, 2 pm CEST

For more information on the call please see the canSERV website: https://www.canserv.eu/calls/open-call-for-transnational-service-provision/